125 related articles for article (PubMed ID: 38744006)
21. Whole-genome sequencing-based analyses of drug-resistant Mycobacterium tuberculosis from Taiwan.
Xiao YX; Liu KH; Lin WH; Chan TH; Jou R
Sci Rep; 2023 Feb; 13(1):2540. PubMed ID: 36781938
[TBL] [Abstract][Full Text] [Related]
22. Integrating informatics tools and portable sequencing technology for rapid detection of resistance to anti-tuberculous drugs.
Phelan JE; O'Sullivan DM; Machado D; Ramos J; Oppong YEA; Campino S; O'Grady J; McNerney R; Hibberd ML; Viveiros M; Huggett JF; Clark TG
Genome Med; 2019 Jun; 11(1):41. PubMed ID: 31234910
[TBL] [Abstract][Full Text] [Related]
23. Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin.
Pillay S; Steingart KR; Davies GR; Chaplin M; De Vos M; Schumacher SG; Warren R; Theron G
Cochrane Database Syst Rev; 2022 May; 5(5):CD014841. PubMed ID: 35583175
[TBL] [Abstract][Full Text] [Related]
24. Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Indonesia.
Chaidir L; Ruesen C; Dutilh BE; Ganiem AR; Andryani A; Apriani L; Huynen MA; Ruslami R; Hill PC; van Crevel R; Alisjahbana B
J Glob Antimicrob Resist; 2019 Mar; 16():170-177. PubMed ID: 30172045
[TBL] [Abstract][Full Text] [Related]
25. A precision overview of genomic resistance screening in Ecuadorian isolates of Mycobacterium tuberculosis using web-based bioinformatics tools.
Morey-León G; Mejía-Ponce PM; Granda Pardo JC; Muñoz-Mawyin K; Fernández-Cadena JC; García-Moreira E; Andrade-Molina D; Licona-Cassani C; Berná L
PLoS One; 2023; 18(12):e0294670. PubMed ID: 38051742
[TBL] [Abstract][Full Text] [Related]
26. Analysis of Serial Multidrug-Resistant Tuberculosis Strains Causing Treatment Failure and Within-Host Evolution by Whole-Genome Sequencing.
Chen X; He G; Lin S; Wang S; Sun F; Chen J; Zhang W
mSphere; 2020 Dec; 5(6):. PubMed ID: 33361124
[TBL] [Abstract][Full Text] [Related]
27. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
[TBL] [Abstract][Full Text] [Related]
28. Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in Ethiopia.
Mesfin EA; Merker M; Beyene D; Tesfaye A; Shuaib YA; Addise D; Tessema B; Niemann S
PLoS One; 2022; 17(8):e0271508. PubMed ID: 35930613
[TBL] [Abstract][Full Text] [Related]
29. Whole-genome sequencing reveals genotypic resistance in phenotypically susceptible
Hasan Z; Razzak SA; Kanji A; Shakoor S; Hasan R
Int J Mycobacteriol; 2023; 12(2):179-183. PubMed ID: 37338481
[TBL] [Abstract][Full Text] [Related]
30. Diversified lineages and drug-resistance profiles of clinical isolates of
Noorizhab Fakhruzzaman MN; Abidin NZ; Aziz ZA; Lim WF; Richard JJ; Noorliza MN; Hani MH; Norhayati R; Zamzurina AB; Farida Zuraina MY; Hisyam MJ; Teh LK; Norazmi MN; Zaki MS
Int J Mycobacteriol; 2019; 8(4):320-328. PubMed ID: 31793500
[TBL] [Abstract][Full Text] [Related]
31. Determining Genotypic Drug Resistance by Ion Semiconductor Sequencing With the Ion AmpliSeq™ TB Panel in Multidrug-Resistant Mycobacterium tuberculosis Isolates.
Park J; Shin SY; Kim K; Park K; Shin S; Ihm C
Ann Lab Med; 2018 Jul; 38(4):316-323. PubMed ID: 29611381
[TBL] [Abstract][Full Text] [Related]
32. Accurate and rapid prediction of tuberculosis drug resistance from genome sequence data using traditional machine learning algorithms and CNN.
Kuang X; Wang F; Hernandez KM; Zhang Z; Grossman RL
Sci Rep; 2022 Feb; 12(1):2427. PubMed ID: 35165358
[TBL] [Abstract][Full Text] [Related]
33. GenTB: A user-friendly genome-based predictor for tuberculosis resistance powered by machine learning.
Gröschel MI; Owens M; Freschi L; Vargas R; Marin MG; Phelan J; Iqbal Z; Dixit A; Farhat MR
Genome Med; 2021 Aug; 13(1):138. PubMed ID: 34461978
[TBL] [Abstract][Full Text] [Related]
34. Genotypic and phenotypic drug resistance patterns of Mycobacterium tuberculosis isolated from presumptive pulmonary tuberculosis patients in Ethiopia: A multicenter study.
Yenew B; Kebede A; Alemu A; Diriba G; Mehammed Z; Amare M; Dagne B; Sinshaw W; Tesfaye E; Beyene D; Abegaz WE
PLoS One; 2024; 19(5):e0303460. PubMed ID: 38753615
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Whole Genome Sequencing-Based Predictions of Antimicrobial Resistance to TB First Line Agents: A Lesson from 5 Years of Data.
Sharma MK; Stobart M; Akochy PM; Adam H; Janella D; Rabb M; Alawa M; Sekirov I; Tyrrell GJ; Soualhine H
Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892433
[TBL] [Abstract][Full Text] [Related]
36. Concordance of targeted and whole genome sequencing for Mycobacterium tuberculosis genotypic drug susceptibility testing.
Cloutier Charette W; Rabodoarivelo MS; Point F; Knoblauch AM; Andrianomanana FR; Hall MB; Iqbal Z; Supply P; Martin A; Rakotosamimanana N; Grandjean Lapierre S
Diagn Microbiol Infect Dis; 2024 Jun; 109(2):116249. PubMed ID: 38537504
[TBL] [Abstract][Full Text] [Related]
37. Application of Amplicon-Based Targeted NGS Technology for Diagnosis of Drug-Resistant Tuberculosis Using FFPE Specimens.
Song J; Du W; Liu Z; Che J; Li K; Che N
Microbiol Spectr; 2022 Feb; 10(1):e0135821. PubMed ID: 35138166
[TBL] [Abstract][Full Text] [Related]
38. Whole genome sequencing of Mycobacterium tuberculosis isolates and clinical outcomes of patients treated for multidrug-resistant tuberculosis in Tanzania.
Katale BZ; Mbelele PM; Lema NA; Campino S; Mshana SE; Rweyemamu MM; Phelan JE; Keyyu JD; Majigo M; Mbugi EV; Dockrell HM; Clark TG; Matee MI; Mpagama S
BMC Genomics; 2020 Feb; 21(1):174. PubMed ID: 32085703
[TBL] [Abstract][Full Text] [Related]
39. Whole genome sequencing for the prediction of resistant tuberculosis strains from northern India.
Saini A; Dadwal R; Yadav R; Kanaujia R; Aggarwal AN; Arora A; Sethi S
Indian J Med Microbiol; 2024; 48():100537. PubMed ID: 38350525
[TBL] [Abstract][Full Text] [Related]
40. Impact of line probe assay-based molecular testing on individualized treatment in patients with rifampicin-resistant tuberculosis: data from the prospective INNOVA4TB cohort study in Ukraine.
Dudnyk A; Hempel M; Lytvyniuk O; Liudkevych H; Matsera V; Nikitchenko T; Blyzniuk S; Molina-Moya B; Preyer R; Domínguez J
Ther Adv Respir Dis; 2024; 18():17534666241249841. PubMed ID: 38817020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
